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With the beginning of this millennium it has become fashionable to only follow ‘evidence-
based’ practices. This generally-accepted approach cruelly negates experience or intelligent
interpretation of pathophysiology. Another problem is that the great ‘meta-analysts’ of the
present era only accept end points that they consider ‘hard’. In the metabolic and nutritional
field these end points are infection-related morbidity and mortality, and all other end points are
considered ‘surrogate’. The aim of this presentation is to prove that this claim greatly negates
the contribution of more-fundamentally-oriented research, the fact that mortality has
multifactorial causes, and that infection is a crude measure of immune function. The following
problems should be considered: many populations undergoing intervention have low mortality,
requiring studies with thousands of patients to demonstrate effects of intervention on mortality;
nutrition is only in rare cases primary treatment, and in many populations is a prerequisite for
survival rather than a therapeutic modality; once the effect of nutritional support is achieved,
the extra benefit of modulation of the nutritional support regimen can only be modest;
cost–benefit is not a valid end point, because the better it is done the more it will cost;
morbidity and mortality are crude end points for the effect of nutritional intervention, and are
influenced by many factors. In fact, it is a yes or no factor. In the literature the most important
contributions include new insights into the pathogenesis of disease, the diminution of disease-
related adverse events and/or functional improvement after therapy. In nutrition research the
negligence of these end points has precluded the development and validation of functional end
points, such as muscle, immune and cognitive functions. Disability, quality of life, morbidity
and mortality are directly related to these functional variables. It is, therefore, of paramount
importance to validate functional end points and to consider them as primary rather than
surrogate end points.
Clinical end points: Muscle function: Immune function: Cognitive function: Evidence-based medicine
Nutritional depletion, or protein–energy malnutrition, has
been associated with a high rate of infection-related
morbidity and mortality (Sullivan, 1995). The association
is implicit because nutritional depletion has been defined
in general as a situation of diminished uptake or intake of
nutrition leading to diminished physiological function. In
the metabolic and nutritional field (septic) morbidity and
mortality are generally considered as the only hard end
points. However, a substantial amount of work shows that:
(1) physiological dysfunction increases the risk of septic
complications and mortality (Rantanen et al. 2000; Dewey
& Saz, 2001; Cabioglu et al. 2002); (2) nutritional markers
are highly correlated with alterations of muscular, immune
and cognitive functions (Gogos et al. 1998; Pearson et al.
2001; Gosker et al. 2003); (3) nutritional support may
improve physiological function (Hiroshige et al. 1998;
Bourdel-Marchasson et al. 2001; Magri et al. 2003). These
findings raise the question of whether physiological func-
tions can be used as hard end points in nutritional studies.
At present, the diagnosis of nutritional depletion and the
follow-up of patients with a precarious nutritional state
rarely include the assessment of physiological function.
Although it appears obvious that nutritional state and
function are linked, lack of clearly defined and validated
functional tests may explain why they are rarely used.
Furthermore, the assessment of physiological functions
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may be expensive, time-consuming or may require an
active participation of the patient, which cannot be
obtained in patients with, for example, critical illness,
dementia or physical handicaps. Thus, at present, func-
tional tests are not used in clinical practice but are
predominantly used in research.
However, physiological function may be a more reliable
and useful end point than infection-related morbidity and
mortality. Indeed, morbidity and mortality are influenced
by many factors. They are, therefore, crude end points of
nutritional intervention and may not be sensitive enough to
detect the benefits of nutritional support. The assessment of
morbidity and mortality in interventional studies that include
individuals with a low mortality rate requires very large
populations. Moreover, the use of mortality as the end
point in nutritional studies appears illogical, as nutrition is
generally a prerequisite for survival and not a therapeutic
modality.
The present article will discuss the role of physiological
function as a ‘surrogate’ for morbidity and mortality. It
reviews the link between physiological function and
mortality, and between nutritional depletion and physio-
logical function, and reports the impact of nutritional
support on physiological function. The focus is on the
importance of nutritional depletion and the effect of total
energy intake, and not on isolated nutritional deficiencies.
It will not only depart from the apparently hard data in the
literature but also highlight how personal ambition and
economy skew the approach to research, data interpretation
and publication.
Evidence-based practice
In clinical practice it has become fashionable to demand
care that is based on evidence. In the classification of
evidence clinical experience is only rated as level 4, while
randomised controlled trials and meta-analyses are rated
as level 1 (Harbour & Miller, 2001). Recommendations
deduced from randomised controlled trials and meta-
analyses are rated as level A and supposedly furnish the
objective undeniable truth. Unfortunately, this supposition
is flawed for at least four reasons:
1. product research tends to be directed by industry,
which encourages investigators to embellish positive
results, not to publish negative data or not to publish
data that cannot be explained exclusively as a result of
nutritional intervention (Daly et al. 1992). Since many
investigators rely financially on industry to carry out
research, it may be difficult for them to remain honest
and unbiased;
2. positive results are required in order to be successful
in healthcare-related careers, because they potentiate
funding and further growth of the research group and
its publications;
3. since negative studies cannot easily be published, the
literature abounds in positive studies, which skew the
meta-analyses;
4. data interpretation of clinical studies made in one
centre by a small number of experienced investigators
is usually difficult. Retrieving data from studies made
by other investigators in variable environments is
likely to introduce major bias and generate hazardous
conclusions.
The unchanging pattern of evidence-based medicine has
created in the minds of many healthcare professionals an
unhealthy freedom to do as they like when no evidence is
available. This approach has created as much harm as
benefit. For example, consider the adage that ‘it has never
been proven in the intensive care unit that nutritional
support is of any benefit’. All researchers have had the
frustrating experience that patients have died from depletion
when they were not fed adequately for prolonged periods
of time. As a result of that generally-felt undeniable truth
no medical ethical committee would ever allow carrying
out a research study in which one group is deliberately
starved for a prolonged period of time. However, the
absence of this type of study precludes proof of efficacy,
which in turn allows some clinicians to claim that it has
never been proven that artificial nutrition is any good in
the intensive care setting. In summary, the randomised
controlled trial is not the one and only route to the truth,
but good clinical studies may still have their value, as will
be discussed.
How should studies be carried out and what
should be the end points?
At first sight mortality is an important end point, but it is
less the ‘yes or no’ factor than is generally claimed.
Obviously, there is virtue in promoting survival in the
intensive care unit, and healthcare professionals promote
survival but not necessarily quality of life, which is
determined by functional ability, muscle force, cognitive
function, clearance from disease or ability to live with
disease without suffering. Thus, living shortly may some-
times bring more benefit to the patient than surviving for a
longer time.
Mortality has numerous aetiologies in addition to
nutritional depletion. Consequently, the result of nutri-
tional intervention or modulation may be only modest. By
choosing mortality as the end point, studies are embarked
on that are doomed to yield indecisive results, because
hundreds of patients are required to achieve statistical
significance. It is here that the trouble starts. The dif-
ference may become statistically significant if an attempt is
made to exclude patients with negative outcome by
changing retrospectively the inclusion criteria, to prolong
the length of observation and/or to perform post-hoc
analyses that eventually increase the likelihood of acci-
dental but statistically significant differences (Moore et al.
1992; Ziegler et al. 1992; Griffiths et al. 1997). Thus,
stressing the importance of mortality as the best end point
in nutrition research handicaps endeavours to demonstrate
the efficacy of nutritional intervention strategies. Enthu-
siastic ‘meta-analysts’ such as Heyland and Koretz claim
that the next hard end point is infectious morbidity.
Infectious morbidity truly reflects the success or failure
of treatment, but it is a very crude measure of immune
function. It suffers from limitations similar to those of
mortality. Septic complications are determined by many
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factors, including the severity of primary disease, surgical
technique, comorbidity, nutritional state and the extent of
inflammation already present before surgery or admittance
to the intensive care unit. Such end points therefore require
very large study populations to reach statistical signifi-
cance. In practice these numbers are difficult to achieve,
leading to non-significant differences between groups as
they are originally defined in the study protocol. In turn,
this position urges the need to stretch the data, look for
non-compliance or to perform post-hoc analyses. Even the
most honest among researchers at times have felt this urge,
and it requires very rigid control of the data analysis,
preferably by exterior parties, to overcome this problem.
Furthermore, infection-related morbidity has not yet
been clearly defined. Although papers that have reported
effects on infection-related morbidity have been rated to
furnish level-1 evidence, the criteria for infection-related
morbidity have been badly defined (Daly et al. 1992;
Ziegler et al. 1992). For example, selective decontamina-
tion of the gut and oro-pharynx has a beneficial effect on
the incidence of ventilator-associated pneumonia but does
not decrease mortality. However, true septic abdominal
complications (abscesses, anastomotic leakage) or true
pneumonias (pneumococci, staphylococci) ostentatiously
increase length of stay, general health state and mortality.
This disparity casts doubt on the validity or the criteria
used to assess ‘septic morbidity’. It is possible that it is
colonisation that is being dealt with rather than infection.
Thus, infection-related morbidity is an important, but
badly-defined, outcome variable that is liable to over-
interpretation or stretching of the data to achieve statistical
significance.
It therefore appears justified to look for end points that
are more directly related to the nutritional intervention and
are part of the hypothesis. If it is hypothesised that
glutamine has a beneficial effect on muscle protein
kinetics, muscle endurance or/and strength should be
employed as the end point. Also, as additional ‘surrogate’
end points it should be ascertained that the proposed effect
on muscle protein kinetics is indeed operative and that
increased muscle performance is achieved. This approach
has several advantages. First, the direct target of the
hypothesis is focused on and the effect of glutamine is
therefore separated from the effects of other factors on
mortality. This approach allows inclusion of fewer
patients, which makes studies more ‘do-able’. Second, the
assessment of protein kinetics improves the scientific
quality of the study, confirms the hypothesised mode of
action and therefore contributes to the knowledge about
metabolism. It even makes the improvement found in the
functional end point more believable. The functions that
can be considered are: muscle function; immune function;
cognitive function, including mood. Unfortunately, the
focus on mortality and (septic) morbidity has distracted
researchers from the functional end points that are still
badly defined.
The proposed approach assumes that only one factor is
different when comparing the effect of modulation of the
nutritional regimen. It is sad to conclude that multi-
modality nutritional intervention has taught researchers
nothing about metabolism, despite all the money that has
been invested, and is now subject to intensive political
debate that will not resolve the issue. There is a belief in
immunonutrition because the individual components
appear to be beneficial in settings that have looked at
functional end points such as inflammatory activity in
Crohn’s disease, vasodilatation in coronary disease or
erectile dysfunction. The reason for the depressingly low
scientific output of multi-modality immunonutrition is that
from the very start the hypothesis of the intervention has
been unclear. n-3 Fatty acids, arginine and RNA have been
combined because they all potentially stimulate enterocyte
proliferation and have trophic effects on the gut mucosa,
which in turn may be beneficial in critically-ill patients.
One misinterpretation has been that stimulation of pro-
liferation or of protein synthesis is all by itself beneficial.
However, enterocyte proliferation and protein turnover are
low in stable healthy situations but accelerated in the case
of mucosal damage, as in coeliac disease, Crohn’s disease
and other inflammatory conditions of the bowel. The next
implicit hypothesis is that gut function has a major impact
on overall health status of patients in intensive care. At
present, the superiority of enteral nutrition over parenteral
nutrition is less evident than it has been in the past. First,
increased permeability of the gut as the cause of multiple
organ failure is much debated, and second, the immuno-
depression ascribed to parenteral nutrition has most likely
resulted from overfeeding and inadequate control of
plasma glucose levels (Moore et al. 1992).
At present, n-3 fatty acids are considered to down
regulate the acute-phase response and thus counteract
trauma or infection. On the other hand, arginine stimulates
the immune response. The underlying hypothesis for the
efficacy of the combination of these compounds is there-
fore confusing, precluding deepening of insight into the
working mechanism of these food substances when they
show clinical benefit. In the literature there is similar con-
fusion. In some studies intervention is considered beneficial
because C-reactive protein decreases in the intervention
group (Windsor et al. 1998), whereas in other studies a
similar benefit is claimed because the levels of IL-6, a pro-
inflammatory cytokine, increase (Santos et al. 1994).
All these considerations lead researchers to try to
formulate functional end points, and to explore whether
measures can be defined that are validated and can easily
be used in clinical studies.
Nutritional state and muscle function
Assessment of muscle function
Protein–energy malnutrition affects the function of periph-
eral and respiratory muscles, which can be tested directly
by measurement of muscle strength and endurance. Cable
tensiometry and non-motorised dynamometry (e.g. hand-
grip strength) are used to assess static peripheral muscle
strength, while the one-repetition maximum method,
representing the maximum amount of weight lifted once
during a standard weightlifting exercise, reflects dynamic
strength (McArdle et al. 1996). Computer-assisted iso-
kinetic methods additionally measure movement patterns
as torques, accelerations and velocities of body segments
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(Keating & Matyas, 1996), but their cost and complexity
limit their use to research with small study populations.
The strength of respiratory muscles can be assessed by
measurements of maximal pressures generated during forced
inspiratory and expiratory efforts (Ramirez-Sarmiento et al.
2002). Muscle endurance, which corresponds to the ability
to maintain a specific isometric force or power level in-
volving combinations of concentric and eccentric muscular
contractions, can be tested by the methods mentioned
earlier or by performance tests. Muscle function can also
be evaluated indirectly through questionnaires on physical
activity. These questionnaires provide information relating
to functional ability, defined as the ability to perform daily
activities without assistance, and thus on quality of life.
Impaired muscle function as a cause of disability
and mortality
The relationship between muscle strength, disability and
mortality has been explored mostly in the elderly. Periph-
eral muscle strength decreases naturally by 12 –15% per
decade from the fifth to the eighth decade in men, while
the decline appears to occur later but at a faster rate in
women (Hurley, 1995).
Several cross-sectional studies report a link between low
muscle strength and the ability of the same limb to perform
muscle labour (Lauretani et al. 2003; Canning et al. 2004;
Ostchega et al. 2004). In longitudinal studies handgrip
strength has been shown to predict the functional disability
that appears 25 years later in men aged 45–68 years
(Rantanen et al. 1999) and 4 years later in men aged 71–91
years (Giampaoli et al. 1999). Handgrip strength at hospital
admission has also been shown to be a good predictor of
reduced functional ability during a median hospital stay of
10 d (Humphreys et al. 2002). These findings imply that
the strength of a single limb is an indicator of the whole
body to perform muscle labour, and that there is a
threshold of muscle strength loss under which disability
occurs. On the basis of these findings Lauretani et al.
(2003) have set up cut-off values of knee-extension torque
and handgrip strength related to a walking speed <0.8 m/s
or a walking ability <1 km in >1000 subjects.
The association between strength and mortality has been
extensively explored. Rantanen et al. (2000) have shown
that in initially-healthy men aged 45–68 years (n 6040) the
mortality rate over a period of 30 years is 24.8 in the
lowest tertile of handgrip strength, 18.5 in the middle tertile
and 14.0 in the highest tertile. The same research group
have found that in elderly moderately-disabled women
handgrip strength in the lowest tertile predicts 5-year
mortality relating to CVD and respiratory disease, inde-
pendently of inflammation, poor nutritional status, physical
inactivity and depression (Rantanen et al. 2003). Ethnicity
does not appear to influence the association between
strength and mortality. Indeed, handgrip strength is pre-
dictive of the 6-year mortality in 7286 Japanese men (Fujita
et al. 1995) and of the 5-year mortality in 2488 older
Mexican Americans (Al Snih et al. 2002). Interestingly, in
the latter study the association between mortality and
handgrip strength was found to remain after controlling for
functional disability, assessed by the Katz activities of
daily living scale and by the instrumental activities of daily
living scale (Al Snih et al. 2002). The strength of the
association may, however, vary according to gender, as
suggested by Stenvinkel et al. (2002), who found that
handgrip strength is predictive of the 3-year mortality in
men but not in women with end-stage renal disease.
Functional disability increases the risk of mortality. Corti
et al. (1994) have shown an increased 4-year mortality
associated with functional disability in > 4500 subjects
aged ‡71 years. This finding that a higher rate of mortality
is associated with disability has been confirmed recently in
the elderly (Persson et al. 2002, von Strauss et al. 2003)
and in patients with chronic obstructive pulmonary disease
(Ranieri, 2001). However, none of these studies has pro-
vided detailed information about the causes of mortality.
Kattainen et al. (2004) have found that disability is
predictive of all-cause and CHD mortality in men and of
all-cause mortality in women 15 years later. Similarly,
disability in activities of daily living before myocardial
infarction has been reported to be related to 6-month
mortality after myocardial infarction (Vaccarino et al.
1997). However, the disabled subjects were older and
suffered from higher comorbidity, which may explain the
higher mortality rate in this group. Thus, disability appears
to promote or aggravate the severity of CVD.
To summarise, muscle weakness predicts both func-
tional disability and mortality. Several studies have shown
the relationship between disability and mortality, but it
is not yet convincingly established whether the patho-
physiological mechanism of this link is muscle weakness
or other factors such as inflammation, disease or cognitive
alterations.
Impaired muscle function as a result of
nutritional depletion
Suggested pathways for impaired muscle function include
malnutrition, systemic inflammation and physical inactivity
(Rantanen et al. 2003; Fig. 1). Studies of the relationship
between muscle function and nutritional state have been
performed in subjects with chronic diseases, the elderly
and surgical patients.
Nutritional depletion
Increased mortality
and morbidity
Decreased muscle function
Decreased muscle
strength
Decreased functional
ability
Inflammation Physical activity
Fig. 1. Clinical factors influencing muscle function and effect on
mortality and morbidity.
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The association between markers of malnutrition and
muscle strength has been demonstrated in several recent
studies. Serum albumin of patients with chronic renal
failure has been found to be inversely correlated with knee
extension and flexion strength, independently of protein
intake or residual renal function (Cupisti et al. 2004). Fat-
free mass has been shown to be positively associated with
quadriceps and biceps strength in subjects with chronic
obstructive pulmonary disease and chronic heart failure
(Gosker et al. 2003). In elderly US outpatients stratified in
tertiles according to their handgrip strength, the percentage
of patients with unintentional weight loss is highest in the
lowest tertile of handgrip strength (Rantanen et al. 2003).
Maximal inspiratory and expiratory pressures are lower in
patients with anorexia nervosa than in control subjects
(Pieters et al. 2000). Since markers of nutritional state are
also influenced by inflammation and disuse, these results
do not, however, quantify the contribution to muscle
weakness of pure nutritional depletion and the resulting
muscle atrophy.
The link between malnutrition and functional disability
has been mainly explored in the elderly. Functional dis-
ability has been related to low scores of the subjective
global assessment or mini nutritional assessment (Persson
et al. 2002), a low waist:hip ratio, low plasma albumin and
transferrin levels (Romagnoni et al. 1999) and a low body
cell mass (Zuliani et al. 2001). A longitudinal study has
shown that in surgical and medical patients hospitalised for
a median duration of 10 d a low score of the subjective
global assessment, fat mass and handgrip strength predicts
a decline in functional status (Humphreys et al. 2002).
Zuliani et al. (2001) suggest three physiopathological
mechanisms to explain the association between malnutri-
tion, diagnosed as low body cell mass, and functional
disability: (1) decreased body cell mass impairs functional
ability through reduced muscle strength; (2) physical dis-
ability decreases body cell mass through inactivity;
(3) inflammation reduces both body cell mass and
functional ability. Indeed, chronic inflammation defined
by elevated IL-6 plasma levels is inversely correlated with
handgrip strength and total power in older subjects
(Barbieri et al. 2003).
Although these studies used different methods and
protocols to assess muscle function, diagnose malnutrition
and follow nutritional state, they show an association
between malnutrition, impaired muscle strength and
functional disability.
Effect of nutritional support on muscle function
Studies relating to the consequences of nutritional inter-
vention provide a better insight into the pathogenesis of
muscle weakness and functional disability. Impaired muscle
function appears 24 h after starvation of well-nourished
subjects but muscle function returns to normal 6 h after the
intake of a meal (Shizgal et al. 1986). Thus, nutritional
supplementation appears to be sufficient to reverse muscle
alterations in well-nourished subjects. This hypothesis
has been verified in well-nourished patients undergoing
elective surgery. The pre-operative intake of nutritional
supplements (1.7–2.1 MJ (400–500 kcal)/d) limits the
post-operative decrease in quadriceps strength (Henriksen
et al. 2003). However, nutritional supplementation does
not improve normal muscle function in well-nourished
subjects. Nutritional supplementation of 1.5–2.1 MJ (350–
500 kcal)/d during a period of 10 weeks–1 year has
been shown to have no effect on muscle function and
functional ability in well-nourished elderly subjects
(Fiatarone et al. 1994; Wouters-Wesseling et al. 2003;
Bunout et al. 2004).
The effect of nutritional supplementation on muscle
function seems to be more controversial in depleted patients.
A meta-analysis has shown that malnourished patients with
chronic obstructive pulmonary disease receiving ‡2 weeks
of oral or enteral nutritional support (1.5–4.2 MJ
(350–1000 kcal)/d) do not improve their respiratory muscle
strength and 6 min walk test (Ferreira et al. 2000). This
result has been confirmed by a more recent double-
blind study in which patients with chronic obstructive
pulmonary disease were randomised to a carbohydrate-rich
supplement (2.4 MJ (570 kcal)/d) or a non-nutritive place-
bo for 7 weeks (Steiner et al. 2003). Underweight subjects
(BMI £19 kg/m2) with energy supplementation do not
increase the time spent walking at 85% of the predicted
VO2max, in contrast with those having a BMI >19 kg/m2.
However, the number of subjects in the malnourished
group was very small. The authors suggest that there is an
exaggerated systemic inflammatory response, leading to
higher energy expenditure, and an obligatory muscle
catabolism, which cannot be overcome by increased energy
intake. On the other hand, nutritional supplementation
improves handgrip and respiratory muscle strength in
malnourished patients with acute exacerbations of inflam-
matory bowel disease (Christie & Hill, 1990), those
awaiting liver transplantation (Le Cornu et al. 2000) and
malnourished elderly subjects (Bourdel-Marchasson et al.
2001). These different outcomes most probably relate to
the criteria used to define malnutrition as well as to
inflammatory state and to the physical activity of the study
populations.
Thus, nutritional support may improve muscle function,
but only in malnourished subjects. Interestingly, this
finding is in agreement with the results of a meta-analysis
demonstrating that nutritional supplementation lowers
mortality only in malnourished subjects (Potter et al. 2001).
Nutritional state and immune function
Assessment of immune function
Immune function has been studied less well in relation to
nutritional state than muscle function. Protein–energy
malnutrition affects both the cellular and humoral immu-
nity, i.e. phagocytic function, cytokine production, genera-
tion of complement factors and the production of secretory
immunoglobulin A (Chandra, 2002; Keusch, 2003). In
present clinical routine immune function is rarely used as a
marker of malnutrition, and in metabolic research immune
function is mainly determined by the number and types of
immune cells circulating in the bloodstream, the immu-
noglobulin levels, the delayed hypersensitivity response
and the occurrence of infectious complications.
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Delayed hypersensitivity response is the response to
intradermal application of an antigen to which a subject
has already been exposed. It is evaluated by the size of
swelling around the application of the antigen, usually 48 h
after application (Calder & Kew, 2002), and reflects cell-
mediated immunity. The foreign antigen is processed
by monocytes and macrophages. These cells secrete IL-1
and IL-6, which stimulate clonal proliferation of antigen-
specific T-cells, and also present the antigen to T-cells
expressing a receptor specific for the antigen. T-cells
(T-helper cells) in turn release cytokines to recruit other T-
cells (T-cytotoxic cells) and macrophages or to directly
damage the tissue. Unfortunately, the use of the delayed
hypersensitivity response has largely been abandoned in
clinical practice, although it is a true functional measure.
The reason is probably that it gave a yes or no response
and that its use is laborious. As a consequence it has not
been further developed and validated as a graded measure
of immune function.
Impaired immune function as a cause of
infection-related morbidity and mortality
In surgical subjects a reduced delayed-type hypersensitivity
skin test during sepsis has been associated with a higher
sepsis-related mortality than a reactive hypersensitivity skin
test (Christou et al. 1995). Patients with septic shock have
a higher percentage of CD4+CD25+ T-cells than healthy
volunteers, and the percentage of CD4+CD25+ T-cells is
increased in non-survivors compared with survivors
(Monneret et al. 2003). Le Tulzo et al. (2002) have found
that patients on day 1 after septic shock exhibit higher
lymphocyte apoptosis than control patients and that the
survivors restore lymphocyte counts by day 6 in contrast
with non-survivors. Cytokines undoubtedly play an essen-
tial role in the development of sepsis but the importance of
plasma cytokine levels is unclear. Only circulating IL-6
appears to be correlated with the development and severity
of sepsis. High serum levels of IL-6 predict the develop-
ment of sepsis in patients after major surgery (Mokart et al.
2002) and in febrile patients (Groeneveld et al. 2003).
Interestingly, Cabioglu et al. (2002) have measured
leucocyte intracytoplasmic cytokines and have shown a
decreased expression of T-lymphocyte-associated IL-6 and
TNFa and monocyte-associated IL-10 and IL-12 in
patients with severe sepsis. This result suggests that the
circulating levels do not automatically reflect the produc-
tion of cytokines and their role in the pathogenesis of
sepsis. Thus, the link between cytokines and morbidity
warrants further research at the cellular level rather than at
the plasma level.
Numerous indices of infection have been related to a
high risk of mortality. In patients with end-stage renal
disease increased neutrophil counts and reduced lympho-
cyte counts have been found to be independent predictors
of mortality (Pifer et al. 2002; Reddan et al. 2003). Other
studies have specified the type of lymphocytes associated
with survival. For example, in patients with HIV elevated
CD4+ cell counts are associated with a high rate of
survival (Melchior et al. 1999), although this result is
controversial (Suttmann et al. 1995). In contrast, CD8+
cell counts are predictive of the 6-month mortality in
severe alcoholic hepatitis (Mendenhall et al. 1995). Poor
outcome is associated with lymphocyte apoptosis and
reduced expression of pro-inflammatory and anti-inflam-
matory cytokines levels in patients with sepsis (Cabioglu
et al. 2002; Le Tulzo et al. 2002), and with IL-6, a
cytokine associated with age-related reduction in muscle
mass, in the elderly (Cappola et al. 2003). The predictive
value of delayed-type hypersensitivity response on post-
operative morbidity and mortality is controversial (Beier-
Holgersen & Brandstrup, 1999).
Thus, as expected, there is a clear relationship between
immune function and infection-related morbidity and mor-
tality. Confusion remains about the best immune marker to
use as an indicator for immune competence and conse-
quently as a predictor for morbidity and mortality.
Impaired immune function as a result of
nutritional depletion
The effect of deficient energy intake on immune function
is most evident in developing countries. Undernourished
children present with a thymic atrophy with alteration of
cellular immunity, resulting in a decreased production of
secretory IgA in the mucosal-associated lymphoid tissue
(Carli et al. 1990). Undernourished adults show an
abolition of fever and leucocytosis in the case of infection,
and only a moderate increase in the synthesis of acute-
phase proteins (Hasselmann et al. 2001).
Only a few recent studies have shown an association
between immune dysfunction and nutritional depletion in
patients with chronic disease. In 25 661 patients under-
going haemodialysis a high lymphocyte count and low
neutrophil count were found to be associated with high
levels of serum albumin and creatinine (Reddan et al.
2003). In sixty patients with generalised malignancy
classified as well-nourished or malnourished according to
weight loss, serum albumin and transferrin as well as to the
Karnofsky state of performance (Gogos et al. 1998), the
absolute numbers of T-cells, the percentages of total T-
cells and CD4+ T-cells were found to be lower in
malnourished subjects than in well-nourished subjects.
Nutritional state was not found to affect the number of
CD8+ T-cells and the serum levels and production of
IL-1, IL-6 and TNFa.
Nutritional state is related to infectious complications in
a vicious circle. Immune dysfunction caused by nutritional
depletion leads to a high occurrence of infectious diseases,
which in turn aggravate nutritional depletion. For example,
depleted children suffer from frequent episodes of infec-
tious disease, and kwashiorkor is precipitated by infection
(Scrimshaw, 2003). Patients who are malnourished suffer
from more-severe infection-related morbidity than those
who are not malnourished, both in the case of acute renal
failure (Fiaccadori et al. 1999) or with acquired megacolon
(Vieira et al. 1996). Pre-operative weight loss before
stricturoplasty (Dietz et al. 2001) and pre-operative serum
albumin levels before gastrointestinal or spinal operations
are also predictors of morbidity (Hu et al. 1998; Kudsk
et al. 2003). Thus, to summarise, nutritional depletion
impairs immune function.
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Effect of nutritional support on immune function
The effect of nutritional supplementation on immune
function has been evaluated in different ways. Research
has focused on the impact of energy intake, the route of
feeding and the addition of isolated nutrients on immune
function and outcome (Lin et al. 1998).
The effect of energy supplementation on the immune
system is controversial (Table 1) and may be related to the
baseline nutritional status. Indeed, in malnourished patients
nutritional support appears to be beneficial (Bozzetti et al.
1995; Hiroshige et al. 1998). However, the effect of
duration and quantity of supplementation, and the effect
of the primary disease should not be neglected.
Interestingly, in moderately-malnourished patients under
semi-elemental enteral or isonitrogenous isoenergetic
parenteral support for at least 10 d there is a similar rise
in lymphocyte counts, levels of complement factor C3,
IgA, IgG and IgM, and a drop in the incidence of negative
skin tests (Georgiannos et al. 1997). This finding is
surprising since Christou et al. (1995) have found that
parenteral nutrition does not correct the delayed-type
hypersensitivity and many cellular immune functions
tested in elective surgical patients. One hypothesis is that
cellular immunity can be influenced differently depending
on the route of feeding. Meta-analyses performed in
critically-ill patients and patients with acute pancreatitis
show that enteral nutrition leads to less infectious
complications than parenteral nutrition (Gramlich et al.
2004; Marik & Zaloga, 2004). In mice parenteral nutrition
decreases IgA levels in intestinal and respiratory secre-
tions, T- and B-cells in the Peyer’s patches, CD4:CD8 in
the intestinal lamina propria and the levels of IL-4 and IL-
10 levels in gut homogenates when compared with enteral
nutrition (Genton & Kudsk, 2003). However, the detri-
mental effect of parenteral nutrition on immune functions
and infectious complications may be explained by total
parenteral nutrition-induced hyperglycaemia, which is
poorly controlled and increases the infectious risk.
Thus, nutritional supplementation may be essential for
proper immune function in malnourished patients but the
effect of the route of feeding on the immune dysfunction
has not been clearly demonstrated in human subjects.
Patients in whom immune functions predict morbidity and
death need to be better defined in terms of nutritional state
and disease.
Table 1. Studies on the effect of energy intake on immune function
Reference Patients Nutrition supplement Length of intake Outcome
Wouters-Wesseling
et al. (2003)
Nineteen elderly
patients
Oral supplement v. non-
energetic placebo
7 months ‹ Ig against influenza A/Beijing
and A/Sydney after vaccination
Schauder et al.
(2002)
Sixty patients
undergoing large-
bowel surgery
Post-operative TPN
v. no TPN
5d ‹ IL-2, IFN-g, TNFa
› IL-2 receptor expression
Van Bokhorst
et al. (2001)
Forty-nine patients
undergoing head-
and-neck surgery
Pre-operative tube feeding
v. no tube feeding
Nine pre-operative
days
No effect on lymphocyte and
leucocyte counts, total T- and
B-cells, CD4+ cells, CD8+
cells, CD14+ cells, NK cells,
NK-like T-cells
Chin et al. (2000) 112 elderly patients Oral micronutrient-
enriched food
v. no supplement
17 weeks No effect on delayed-type
hypersensitivity response
Powell et al.
(2000)
Twenty-seven patients
with acute pancreatitis
Early enteral feeding
v. no feeding
4d No effect on IL-6, TNF receptor-1,
CRP
Hiroshige et al.
(1998)
Twenty-eight haemodialysis
patients
IDPN v. no IDPN 1 year ‹ Total lymphocyte counts
McCarter et al.
(1998)
Patients undergoing
gastrointestinal
operations
Oral supplement
v. no supplement
Seven pre-operative
days
No effect on lymphocyte prolife-
ration or monocyte function
Bozzetti et al.
(1995)
Nine cancer patients TPN Median 10d ‹ NK cell activity
‹ IgM
Sacks et al. (1995) Nine patients with
head injury
TPN starting on day 1
v. starting on day 5
14d ‹ CD4, CD4:CD8 and T
lymphocyte responsiveness
to Con A
Bunker et al.
(1994)
Thirty-nine elderly patients Oral supplement v.
no supplement
12 weeks No effect on lymphocyte
population
Minimal effect on delayed-type
hypersensitivity response
Fan et al. (1994) Sixty-four patients under-
going hepatectomy
TPN peri-operative + oral
diet v. oral diet
14 peri-operative
days
› Infection-related morbidity
IDPN, Intradialytic parenteral nutrition; TNP, total parenteral nutrition; IFN-g, interferon-g; NK, natural killer; CRP, C-reactive protein; Con A; concanavalin A; ‹ ,
increase; › , decrease.
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Nutritional state and cognitive function
Assessment of cognitive function
Neisser (1967) has stated that ‘the term ‘cognition’ refers
to all the processes by which the sensory input is trans-
formed, reduced, elaborated, stored, recovered, and used.
Such terms as sensation, perception, imagery, retention,
recall, problem-solving, and thinking, among many others,
refer to hypothetical stages or aspects of cognition’.
Cognitive function can be assessed using clinical tests,
neuropsychological tests, electroencephalography, clinical
ratings and computerised test batteries. However, meta-
bolic studies generally rely on clinical tests, such as the
mini mental state examination, because they are easier and
cheaper to perform than the other available tests (Riedel &
Jorissen, 1998).
Impaired cognitive function as a cause of mortality
Research on cognitive function is gaining increasing in-
terest because the world population is getting older.
Cognitive function has been related to age, educational level
and profession (Schiel et al. 2003). A recent meta-analysis
has shown that even low levels of cognitive impairment in
the elderly lead to an increased risk of mortality, but
cannot clearly identify the causes of death (Dewey & Saz,
2001). Pneumonia and congestive heart failure have been
found to be the primary cause of death in elderly patients
with Alzheimer’s disease (Janicki et al. 1999), but risk of
death from stroke has also been associated with cognitive
function (Gale et al. 1996). However, cognitive function at
the time of performing a gastrostomy is not predictive of
1-year mortality (Bannerman et al. 2000).
A confounding factor for the relationship between
cognitive function and mortality may be the presence of
physical disability. However, mental impairment has been
found in two studies to be a strong predictor of death
independently of physical disability (De Andino et al.
1995; Noale et al. 2003).
Impaired cognitive function as a result of
nutritional depletion
In many publications a correlation has been demonstrated
between cognitive function and nutritional depletion.
However, the cause–effect relationship is not yet clear,
and nutritional depletion is potentially linked to cognitive
impairment by a vicious circle similar to that associating
nutritional depletion and immune function.
Dementia has been associated with nutritional depletion,
defined by the mini nutritional assessment (Pearson et al.
2001; Magri et al. 2003). Elderly individuals with
diminished cognitive function and functional ability have
>2-fold higher risk of being nutritionally depleted (Pearson
et al. 2001). Furthermore, the scales used to determine
the severity of dementia (Bedford Alzheimer nursing
severity scale or clinical dementia rating) can differentiate
patients who are malnourished, according to the prognostic
nutritional index, from those who are not malnourished
(Bellelli et al. 1997). A decrease in cognitive function
has also been related to weight loss and a low BMI
(Irving et al. 1999; Ponzer et al. 1999; Faxen-Irving
et al. 2002). A longitudinal study conducted over a
period of 5 years has shown that healthy elderly
subjects with a BMI between 23 and 27 kg/m2 have a 3.6
lower risk of cognitive decline in the subsequent 5 years
(Deschamps et al. 2002). However, serum albumin, energy
intake, serum creatinine and calf circumference are not
associated with the mental component summary score
of the SF-36 (questionnaire commonly used to assess
quality of life) in 1545 haemodialysis patients (Allen et al.
2002).
Although there appears to be an association between
cognitive function and nutritional markers, it remains
unclear whether the disease itself, its pharmacological
therapy, the functional disability or nutritional depletion
leads to cognitive impairment.
Effect of nutritional support on cognitive function
Energy intake is associated with cognitive function. In 168
elderly subjects whose dietary intake was monitored using
a food record for seven consecutive days individuals with
satisfactory intellectual function (mini mental state exam-
ination >28) were generally found to have a greater intake
than those with cognitive impairment (Requejo et al.
2003). These findings confirm earlier data from Ortega
et al. (1997). Interestingly, these studies also indicate that
the composition of the diet relates to cognitive function,
suggesting that the intake of specific micro- or macro-
nutrients may have a greater impact on cognitive function
than total energy intake. Huijbregts et al. (1998) have
calculated a healthy diet indicator, based on the World
Health Organization (2003) guidelines for the prevention
of chronic diseases, using dietary histories for 1049 elderly
men from Finland, The Netherlands and Italy, and they con-
cluded that a healthy diet might be associated with a better
cognitive function. Similar results have been reported by
Correa Leite et al. (2001).
Studies of the effect of nutritional supplementation on
cognitive function are scarce. It has been found that 5
months of oral supplementation (1.7 MJ (410 kcal)/d) of
elderly subjects living in community-assisted housing
results in weight gain but does not reduce the rate of
decline in cognitive or functional capacity compared with
subjects who received no supplementation (Faxen-Irving
et al. 2002). In contrast, malnourished patients receiving
dietary supplements for a mean duration of 45 d show an
improvement in cognitive function, although the authors
have concluded that there may be a confounding effect of
pharmacological therapy for dementia (Magri et al. 2003).
The impact of increased energy intake on cognitive func-
tion is not convincing so far, but it may prevent further
deterioration of nutritional state in demented patients and
thus lead to a lower rate of infectious events and mortality,
as demonstrated by Gil Gregorio et al. (2003).
Conclusion
Large multi-centre studies addressing the clinical effects of
nutritional interventions are useful if their power is suf-
ficient and if their evaluation is independent of industrial
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pressure. It is suggested, however, that functional indices
should be validated more thoroughly. They can be used in
smaller studies and, when associated with surrogate end
points, can give valuable information on the physiological
and metabolic mechanisms of disease.
Nutritional depletion leads to alterations in muscle
function and possibly cognitive and immune function.
Nutritional supplementation can reverse some of the
physiological dysfunctions occurring with nutritional
depletion, but confounding variables are numerous. Never-
theless, because muscle strength consistently predicts
morbidity and mortality, it is suggested that this variable
is used as a hard marker of malnutrition-related morbidity
and mortality. Immune function may be a welcome end
point when sufficient knowledge exists about the benefit
and/or harm of host response, and when variables
evaluating the adequacy of immune function have been
validated. Nutritional support may prevent cognitive
decline in the elderly, but cognitive variables also clearly
warrant further validation.
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